Sharon Mates, Intra-Cellular Therapies CEO
March 28, 2023 11:12 AM EDT
R&D

In­tra-Cel­lu­lar Ther­a­pies gets a boost on PhI­II de­pres­sion drug da­ta

Tyler Patchen

News Reporter

Biotech In­tra-Cel­lu­lar Ther­a­pies tout­ing new da­ta Tues­day for its drug de­signed to treat ma­jor de­pres­sive dis­or­der.

The biotech shared re­sults from …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

VP, Clinical Development / CMO / CDO‬ ‭ (Stealth Portfolio Company)

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

Lil­ly meets sales ex­pec­ta­tions, but No­vo gains on PBM win

Mod­er­na ex­pands ef­fort to rein in costs in an ‘un­cer­tain en­vi­ron­ment’

Ex­its con­tin­ue at FDA, as more staff in drug of­fice fol­low fired col­leagues out the door

Ex­clu­sive: Ex-Cal­i­co sci­en­tist launch­es State­ly Bio with new way to study cells

Am­i­cus grabs Dimer­ix’s rare kid­ney dis­ease drug for $30M up­front

sponsored

Rev­o­lu­tion­iz­ing obe­si­ty treat­ment: Could mi­to­chon­dria hold the key to un­lock­ing fat-spe­cif­ic weight loss?

A service from the Financial Times